Clinical Trials on Bone Marrow Donation in Italy

Total 1318 results

Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study (ATREMA)

Bone Marrow Donors

Italy
University of Milan

Completed

New Topographic Classification of Knee Bone Marrow Lesions (ncbe)

Knee Bone Marrow Lesions

Italy
Zimmer Biomet

Completed

Subchondroplasty Procedure in Patients With Bone Marrow Lesions

Bone Marrow Edema | Bone Marrow Lesions

Germany, Netherlands, Italy, Spain, United Kingdom
Federico II University

Unknown

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Nonmalignant Neoplasm

Italy
Istituto Ortopedico Rizzoli

Terminated

Study for the Treatment of the Bone Marrow Edema:Core Decompression VS Bone Marrow Concentrate (BMC) VS Bone Substitute (BME-TARGET)

Bone Marrow Edema

Italy
University of Milan

Completed

Clinical and Radiological Outcomes of Subchondroplasty in the Treatment of Bone Marrow Edema of the Knee

Bone Marrow Edema

Italy
European Institute of Oncology

Recruiting

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Lymphoma | Leukemia | Aplastic Anemia | Leukemia, Acute | Leukemia, Chronic

Italy
Centro di Riferimento Oncologico - Aviano

Recruiting

Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)

Multiple Myeloma

Italy
Istituto Ortopedico Rizzoli

Completed

Surgical Treatment of Long Bone Metastases (MTC)

Surgery | Bone Metastases

Italy
European Society for Blood and Marrow Transplantation
Genzyme, a Sanofi Company

Completed

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (RATGAA07)

Aplastic Anemia

Switzerland, United Kingdom, Germany, Italy, France, Saudi Arabia
Istituto Ortopedico Rizzoli

Completed

Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients (PreMetOn)

Bone Metastases

Italy
Aqueduct Medical Ltd
Sintesi Research Srl

Completed

Effectiveness and Safety Evaluation of Aqueduct -100 Device

Cervix Uteri Dilation

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Short Course Radiation Therapy in Palliative Treatment of Complicated Bone Metastases

Bone Metastases | Palliative Care | Radiotherapy

Italy
AUSL Romagna Rimini

Completed

PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES

Myeloproliferative Neoplasm

Italy
Azienda Ospedaliera San Gerardo di Monza

Completed

Evaluation of a Closed Suction System to Remove Secretions From the Endotracheal Tube

Intubation | Expected Duration of Ventilation > 48h

Italy
Italfarmaco

Completed

Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases

Myeloproliferative Diseases

Italy
Istituto Clinico Humanitas

Completed

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

Infection | Graft Vs Host Disease | Hematological Malignancy | Bone Marrow Transplant Complications | Bone Marrow Transplant Infection

Italy
Federico II University

Completed

Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm | Prefibrotic/Early Primary Myelofibrosis

Italy
Federico II University

Unknown

Effects of FSH on Endothelial Function (FEND) (FEND)

Change in Flow Mediated Dilation

Italy
Hoffmann-La Roche

Terminated

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera

Polycythemia Vera

United States, Canada, Italy, Australia
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Real World Evidence of Fedratinib Effectiveness in MF (REALFed)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

Italy
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Recruiting

Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases (BC-BOMET)

Bone Metastases | Breast Cancer Metastatic

Italy
medac GmbH
Syneos Health; Celerion; Venn Life Sciences

Completed

Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

Bone Marrow Failure Syndromes | Inborn Errors of Metabolism | Primary Immunodeficiencies | Haemoglobinopathies

Poland, Czechia, Germany, Italy
Margherita Maffioli

Unknown

Ruxolitinib in Myelofibrosis Patients in Lombardy, Italy

Myelofibrosis

Italy
European Society for Blood and Marrow Transplantation
Novartis; Pfizer

Completed

hATG+CsA vs hATG+CsA+Eltrombopag for SAA (RACE)

Severe Aplastic Anemia

Switzerland, Netherlands, France, Italy, Spain, United Kingdom
Novartis Pharmaceuticals

Terminated

A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)

Primary Myelofibrosis

Spain, Germany, Italy
PharmaMar

Completed

Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis

Myelofibrosis

United States, Italy
Sintetica SA
Cross S.A.

Completed

Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.

Short Duration Lower Limb Surgery Via Spinal Anaesthesia

Italy
European Institute of Oncology

Recruiting

Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET) (MONET)

Bone Metastases | Neuroendocrine Neoplasm

Italy
Italfarmaco

Completed

Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera (PV)

Polycythemia Vera

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Clinical and Laboratory Characteristics of Polycythemia Vera (PV-ARC)

Polycythemia Vera

Italy
Santa Casa de Porto Alegre

Completed

Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS

Bone Metastases

Canada, Brazil, Italy
Novartis Pharmaceuticals

Completed

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia (SOAR)

Severe Aplastic Anemia

Spain, Italy, Hong Kong, Thailand, Korea, Republic of, Mexico, Turkey, India, Brazil
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Istituto Clinico Humanitas

Completed

Efficacy and Safety of Luspatercept: A Study by Fondazione Italiana Sindromi Mielodisplastiche (FISiM-Luspa)

Myeloid Dysplasia

Italy
Italfarmaco

Completed

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

Polycythemia Vera

Germany, Poland, United Kingdom, Italy, France
Incyte Corporation

Terminated

Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia

Myeloproliferative Neoplasm (MPN)

United States, Italy
Consorzio Mario Negri Sud
Agenzia Italiana del Farmaco; A.O. Ospedale Papa Giovanni XXIII

Terminated

Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) (CYTO-PV)

Polycythemia Vera

Italy
European Society for Blood and Marrow Transplantation
CHUGAI sanofi-aventis

Terminated

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

Aplastic Anaemia

France, Netherlands, Germany, United Kingdom, Switzerland, Italy, Sweden, Greece, Czechia
UMC Utrecht
Turku University Hospital; University of Bologna; University of Roma La Sapienza and other collaborators

Recruiting

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases (FURTHER)

Quality of Life | Pain | Neoplasm Metastasis | Bone Cancer | Bone Metastases | Tumor | Bone Neoplasm | Bone Lesion | Cancer Induced Bone Pain

Netherlands, Germany, Finland, Italy
Fondazione per la Ricerca Ospedale Maggiore
AOP Orphan Pharmaceuticals AG

Completed

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV (Low-PV)

Polycythemia Vera

Italy
Fondazione per la Ricerca Ospedale Maggiore

Completed

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study (ERNEST)

Myelofibrosis

Italy, Spain, Sweden
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Completed

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (BIOFER12)

Myelofibrosis | Aplastic Anemia | Myelodysplasia

Italy
Istituto Clinico Humanitas

Active, not recruiting

GENOMED4ALL: Improving MDS Classification and Prognosis by AI

Myelodysplastic Syndromes

Italy
University of Milano Bicocca

Completed

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients (ISAV)

Chronic Myeloid Leukemia

Canada, Germany, Israel, Italy, Spain
AOP Orphan Pharmaceuticals AG
PharmaEssentia (Co-Sponsor for USA)

Completed

Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera (PROUD-PV)

Polycythemia Vera

Spain, Belgium, Austria, Italy, Bulgaria, Czech Republic, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine
Novartis Pharmaceuticals

Completed

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. (RESPONSE-2)

Polycythemia Vera

Hungary, Italy, Belgium, Germany, Spain, Korea, Republic of, Israel, Canada, Turkey, France, Australia, India
Università degli Studi di Brescia

Completed

Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

Chronic Myeloid Leukemia

Italy
Galecto Biotech AB
OPIS s.r.l

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

Myelofibrosis

Germany, Italy, United States, Australia
University of Bologna
Novartis

Completed

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) (CML022)

Chronic Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Terminated

Velcade in Myelodysplastic Syndrome - Pilot Study

MDS

Italy

Clinical Trials on Bone Marrow Donation in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations